This is a community-generated profile. If you would like to claim it, please .
Developing a cell-based therapy
Promethera Biosciences Funding
$0
22 rounds
Promethera Biosciences has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on November 1, 2016.
Funding Rounds
C
$11000000Series CNov 2016
C
$31400000Investors of Promethera Biosciences
Life Sciences Partners
Boehringer Ingelheim
Develops and manufactures pharmaceuticals for humans and animals
Shire
Mitsui & Co. Global Investment
Mitsui & Co.
One of the largest sogo shosha in Japan
Rounds
C
Boehringer Ingelheim Venture Fund
Rounds
C
Mitsubishi UFJ Capital
Rounds
C
FPIM-SFPI Belgium
Rounds
C